Company intelligence / Profile preview

Hymed Group

Bethlehem, Pennsylvania, United States

Ownership: Private
Development stage: Other

Overview

Hymed Group's products are commercially available and have demonstrated strong clinical efficacy and safety, particularly in wound healing and tissue repair. Their proprietary collagen and glycosaminoglycan products have been shown in both clinical evidence and published research to accelerate healing and provide superior outcomes compared to standard modalities[1][4].

Therapeutic areas: OphthalmologyRheumatologyDermatologyOther
Modalities: BiologicProteinPeptidesSmall moleculeNutritional supplement
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Hymed Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hymed Group.

Explore the full profile